“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Recent Posts in Vaccination

Page 1 of 47

New Typhoid Fever Vaccine Prequalified by WHO

New Typhoid Fever Vaccine Prequalified by WHO

The World Health Organization (WHO) has prequalified the first conjugate vaccine for typhoid fever. The new typhoid fever vaccine, Typbar-TCV, is produced by Bharat Biotech International of Hyderabad, India. Prequalification means that the vaccine meets the WHO’s “acceptable standards of quality, safety and efficacy” and will now be available to be purchased by organizations promoting global vaccine programs such as UNICEF and Gavi (Global Alliance for Vaccines & Immunization), also known as The Vaccine Alliance.

New Human Fetal Cell Line Available for Vaccine Production

Since the 1960s, a number of vaccines have been manufactured using “human-diploid fibroblast cell cultures”—cells from tissue of aborted human fetuses.1 2 3 4 5 They include the following 11 vaccines listed on the Centers for Disease Control and Prevention’s (CDC) Vaccine Excipient & Media Summary table: Adenovirus; DTaP-IPV/Hib (Pentacel); DTaP-IPV (Quadracel); Hep A (Havrix); Hep A (Vaqta); Hep A/Hep B (Twinrix); MMR (MMR-II); MMRV (ProQuad); Rabies (Imovax); Varicella (Varivax); Zoster (Shingles – Zostavax).

Influenza Vaccine Effectiveness a ‘Dismal 10 Percent’

Influenza Vaccine Effectiveness a ‘Dismal 10 Percent’

On Feb. 26, 2015, the Centers for Disease Control and Prevention (CDC) estimated the effectiveness of the vaccine against the predominant influenza A H3N2 viruses for the 2014-2015 season at 18 percent—a level reportedly described by CDC researchers as having “little to no efficacy.”

Page 1 of 47